BeyondSpring Inc. SEC filings BYSI
BeyondSpring Inc. has 264 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Sep 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 18, 2025 | — |
| EFFECT | Filing | Jul 12, 2024 | — |
| CORRESP | Letter to the SEC | Jul 10, 2024 | — |
| CORRESP | Letter to the SEC | Jul 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2023 | — |
| EFFECT | Filing | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 9, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2021 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2020 | — |
| EFFECT | Filing | Oct 21, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2019 | — |
| CORRESP | Letter to the SEC | Oct 17, 2019 | — |
| UPLOAD | Letter from the SEC | May 17, 2018 | — |
| CORRESP | Letter to the SEC | May 16, 2018 | — |
| UPLOAD | Letter from the SEC | May 14, 2018 | — |
| EFFECT | Filing | May 3, 2018 | — |
| CORRESP | Letter to the SEC | May 1, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2018 | — |
| D | Filing | Mar 21, 2017 | — |
| EFFECT | Filing | Mar 8, 2017 | — |
| CERTNAS | Auto-generated paper document | Mar 8, 2017 | — |
| CORRESP | Letter to the SEC | Mar 6, 2017 | — |
| CORRESP | Letter to the SEC | Mar 6, 2017 | — |
| 8-A12B | Form 8-a | Mar 6, 2017 | — |
| CORRESP | Letter to the SEC | Mar 2, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2017 | — |
| CORRESP | Letter to the SEC | Feb 28, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2016 | — |
| CORRESP | Letter to the SEC | Nov 15, 2016 | — |
| DRSLTR | Filing | Oct 25, 2016 | — |
| DRS/A | Filing | Oct 25, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2016 | — |
| DRSLTR | Filing | Sep 19, 2016 | — |
| DRS/A | Filing | Sep 19, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2016 | — |
| DRS | Filing | Jun 30, 2016 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BYSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1677940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.